코로나 2차 백신을 10주 넘어서 맞게 된 이유

1차를 맞고 주변에 부작용 얘기 때문에 2차 맞기가

두려워졌다.

하지만 백신패스 등으로 불편함이 증가하면서

2차를 맞을 수 박에 없다는 생각이 들었는데

그런데 자꾸 중요한 일이 생기면서 미루게 되어

11주차 쯤 2차를 맞게 되었다.

한편으로는, 간격을 멀리 맞는게 부작용을 완화시켜주지 않을까?

하는 뇌피셜적인 생각도 갖고 있었는데

참고할 만한 기사가 있어 올려본다.

하지만 코로나백신은 의견이 다 제각각이라 믿을 수 있는게 별로 없기도 하다.

---

 

기사 요약 :

1번 기사 - 코로나감염이 되었던 미성년자 학생들은 백신을 맞으려면 감염 이후 12주 후에 맞아야 부작용 위험이 줄어든다.

2번 기사 - 12주 간격으로 백신을 맞았을 때 부작용이 덜 했다는 일화가 많았다. (증명x)

---

1. UK under-18s with Covid advised to wait 12 weeks for vaccine dose

 

Delay could help to reduce ‘very small’ risk of heart inflammation after jab, experts say

A child testing at home for Covid. It is estimated that about half of secondary school pupils have had the virus. Photograph: Martin Gibbs/Rex/Shutterstock

 

PA Media

Thu 18 Nov 2021 08.05 GMT

 

 

Children aged 12 and over who have had a Covid-19 infection should not get a vaccine until 12 weeks later, UK officials have said.

Deferring could help to reduce even further the “very, very small” risk of heart inflammation after vaccination, experts from the UK Health Security Agency (UKHSA) said.

Current case rates of myocarditis after vaccination among under-18s are suspected to be about nine in every million vaccinations, and cases have been “relatively mild”, officials said.

The advice for older people and for people at high risk from Covid-19 – including those aged 12 and over – is that they should wait four weeks between Covid infection and having a dose of vaccine. But officials said this should be extended to 12 weeks in lower-risk children between 12 and 17.

 

It is thought that a natural Covid-19 infection in younger people provides them with at least three months’ protection, and perhaps six months.

On Monday the Joint Committee on Vaccination and Immunisation (JCVI) said 16- and 17-year-olds could book their second Covid vaccine 12 weeks after their first. But the UKHSA said that should people in this age group be infected with Covid-19 after their first dose, they should delay the second dose until 12 weeks after the infection.

Those still waiting to book their first dose who have had a natural infection should also delay for 12 weeks. The JCVI has not yet advised on second jabs for healthy 12- to 15-year-olds.

Officials estimate that about half of secondary school pupils have had Covid. They said children should only stick to the 12-week deferral if they have had a confirmed case.

Experts reiterated that the risk of myocarditis and other side-effects was “largely in the first few days. So if people had that vaccine three or four weeks ago, within a month of them having had previous infection, and are now fine, they can be reassured they’re past that period of potential risk.”

Any young person who had the jab in the last few days would have been given information about potential side-effects and what to look out for, they added. “Within a few days everyone will have moved through that risk period, so hopefully we can reassure people,” a senior official close to the programme said.

From Thursday, vaccination workers will start doing verbal checks to assess whether children have had a confirmed natural infection in the last 12 weeks.

People are encouraged to get their jab even if they have had previous infection to get as much protection as possible. Researchers from the Covid Zoe Symptom study have said infection before double vaccination provides much greater protection, which supports the call for everyone to get vaccinated even if they have already had Covid.

 

2. Take Another Look at the Spacing Between COVID Vaccine Doses

— Growing body of research suggests robust immune response with extended dosing interval

by Martin Makary MD, MPH, Editor-in-Chief, MedPage Today September 1, 2021

 

 

Beyond only better immunity in the long-term, other considerations contribute to the present-day case for spacing the two doses. There are numerous anecdotal experiences suggesting that the typical vaccine side effects such as fatigue and malaise may be less common when the second dose is spaced at 3 months. The current short interval between vaccine doses may contribute to the rash of myocarditis cases we have seen in children. The heart complications are clustered after the second vaccine dose. (Incidentally, a Tel Aviv study found that a single dose of the Pfizer vaccine alone was 100% effective in children 12-15 years of age.) Such preliminary observations merit further study.